Abstract

Voriconazole is the current standard therapy for invasive aspergillosis. However, its use is limited by toxicity, pharmacokinetic variability, and

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call